Creating pharmacists of tomorrow

Published on

St. Joseph’s Health Care London has launched a unique residency program for pharmacists focused on outpatient chronic disease management.

As the complexity of chronic diseases evolve and rates rise in Canada, St. Joseph’s Health Care London hopes to help create a new generation of pharmacists with expertise in outpatient care of a rapidly growing patient population.

St. Joseph’s has launched a residency program for pharmacists focused on outpatient chronic disease management and the critical role of pharmacists in providing wholistic care to patients. The intensive, one-year program for new pharmacy graduates is one of few in Canada providing hands-on training in team-based, outpatient hospital care for chronic diseases and conditions. With placements at all five St. Joseph’s sites and in a variety of clinical settings, the pharmacy resident will complete training within the Pain Management Program, Rheumatology Centre, Palliative Care Unit, Rehabilitation Program, Mental Health Care Program, and the organization’s outpatient community pharmacy, with electives available in forensic mental health care and other specialties. 

Particularly unique is what the pharmacy resident will learn about the connection between chronic disease, mental health and rehabilitation, establishing trusting relationships with patients, and the integral role of pharmacists as a member of a broad team of health care professionals, explains Denise Kreutzwiser, who led the development of St. Joseph’s pharmacy residency program.

“No other Canadian pharmacy residency program offers an intensive focus in interdisciplinary chronic pain management or rheumatology, addressing a critical need identified by the national bodies of those specialties to better understand and serve those living with chronic pain or rheumatic and musculoskeletal diseases,” says Denise. 

With applicants applying from as far as Qatar and Australia, the successful inaugural pharmacy resident is Sumani Vij, a graduate of University of Waterloo’s School of Pharmacy. Drawn to the ambulatory care focus at St. Joseph’s, Sumani says the training opportunity is the ideal middle ground between acute care and community pharmacy work. 

“You’re able to create pharmacist-patient relationships, which I really like,  but also to collaborate with many allied health professionals – social workers, occupational therapists, nurses, physiotherapists and others,” says Sumani. “You get the best of both worlds.”

While pharmacy rotations during the four years of pharmacy school are compulsory, a residency after graduating and passing the certification exams is voluntary, explains Denise. A residency is additional training that provides pharmacists with proficiency in a particular area. There are only 130 residency spots across Canada for year one pharmacy residents – predominantly in hospital acute care pharmacy.

“Our program is so unique because it’s not an acute care hospital residency program,” says Denise, a pharmacist with St. Joseph’s Pain Management Program. “There are just a handful of ambulatory or chronic disease-based residency programs in the country.”

The program, she adds, embraces the continuity of care concept. An inpatient rehabilitation rotation provides the pharmacy resident with insight into how patients with chronic conditions travel through the health care system and how pharmacists support patients during transitions in care.

Not only does the pharmacy resident emerge from St. Joseph’s with proficiency in chronic disease management but also in helping patients make important changes to improve their health. It’s the only Canadian residency program providing 30 hours of specialized training aimed at helping health care providers support patients in making lasting behaviour changes for overall wellness.

“These elements, along with the unique culture at St. Joseph’s, having patients and caregivers help shape the program to ensure their perspective and lived experience is featured, and the provision of care through the lens of equity, diversity, inclusion and belonging creates a learning experience like no other,” says Denise.

For Sumani, it was the opportunity she was seeking. Particularly intriguing,  says the driven 25-year-old, “is the focus on chronic pain and mental health, how complex and intermingled they can be, and the pharmacist’s role in supporting patients and making sure they are being treated wholistically – from all angles and by multiple disciplines.”

She also looks forward to an elective in forensic mental health care – a rare  learning opportunity in Canada –  and a rotation in palliative care, which she describes as another unique role for pharmacists because “it’s about looking less at what you can prescribe and more at what you can take away to ensure the patient’s comfort.”

While just getting underway, St. Joseph’s pharmacy residency program has already drawn attention with numerous applicants for the first year and other organizations reaching out for advice on setting up their own residency programs, says Andrey Andriets, Director of Pharmacy Services. The plan is to grow the program and offer more than one spot in
subsequent years. 

“Pharmacy Services is pleased to contribute to the extensive teaching role of St. Joseph’s and advance pharmacy learner opportunities with a focus on ambulatory care of tomorrow,” say Andrey.

Sumani chose pharmacy as a profession because of its growth and evolution in recent years related to prescribing powers, opportunities to forge relationships with patients, and the diverse workplace options. As she begins her learning journey at St. Joseph’s, she looks forward to gaining experience, confidence and knowledge that will shape her future career, and all the possibilities that loom. 

“Within pharmacy there’s a whole world to explore and I want to see where I fit best,” says Sumani. “St. Joseph’s residency program is super well rounded and offers really unique electives. I’m excited by everything it offers. I want to learn and create a better version of myself.” 

Latest articles

New approach opens door to better-targeted treatments and faster drug discovery for complex diseases

McGill researchers have developed an AI tool called SIDISH that identifies high-risk cancer cells driving aggressive disease, enabling more precise and targeted treatment strategies. By linking single-cell data with patient outcomes, the tool can predict disease progression and simulate responses to potential drug targets, helping accelerate drug discovery and repurposing. While still in development, SIDISH shows promise for advancing personalized cancer care and improving outcomes across multiple tumour types.

Canadian Cancer Society urges lowering colorectal cancer screening age to 45

The Canadian Cancer Society is urging provinces to lower the colorectal cancer screening age from 50 to 45, citing rising rates among younger adults and evidence that earlier screening could prevent over 15,000 cases and 6,100 deaths. Younger patients are more often diagnosed at advanced stages, making early detection critical. Expanding access to simple screening tools like FIT tests could significantly improve outcomes and save lives.

Unleashing natural killer cells against cancer

Researchers at McGill University have developed a new strategy to enhance natural killer (NK) cells, enabling them to better penetrate tumour defenses and destroy cancer cells. Using small-molecule drugs to temporarily boost NK cell activity—rather than permanent genetic modification—the approach showed strong results against multiple hard-to-treat cancers in preclinical studies. The scalable, ready-to-use therapy could make immunotherapy faster, safer, and more accessible, with future clinical trials planned for aggressive cancers like acute myeloid leukemia.

Doctors report false health information, lack of health data sharing put patient care at risk

A new CMA survey reveals major risks to patient care in Canada, with 99% of physicians reporting that disconnected health systems limit access to critical patient information and nearly half witnessing serious adverse outcomes as a result. At the same time, 97% of doctors say they have intervened to address harm caused by false or misleading online health information, including AI-generated advice. The findings highlight the urgent need for integrated digital health systems and stronger efforts to promote reliable health information.

More like this

CARE Centre and Sunnybrook Health Sciences Centre Partner to Support Internationally Educated Nurses’ Integration

When CARE Centre for Internationally Educated Nurses (IENs) opened its doors 25 years ago,...

Empowering Canada’s health leaders for the AI era: The Health AI Academy takes learning coast-to-coast

HN Summary • Unity Health Toronto’s Data Science and Advanced Analytics team launched the Health...

Training that saves lives: Using simulation to strengthen teams and patient care

Over the past three years, simulation activity at Providence has increased by 30 per...

A national leader in specialized training for nurse practitioners

HN Summary • Hamilton Health Sciences launched Canada’s first nurse practitioner fellowship in hematology, marking...

Sunnybrook welcomes third cohort of work-integrated learning students

HN Summary • Sunnybrook welcomed its third cohort of Black students through York University’s Work-Integrated...

St. Michael’s Hospital endoscopy training program draws experts and students from around the world

HN Summary • Participants from around the world took part in North America’s oldest and...